Institutional investors purchased a net $2.0 million shares of IMMU during the quarter ended December 2014, and now own 42.72% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST PRIVATE INVESTMENT MANAGEM... Bought 157.7 Thousand shares of Immunomedics Inc
SATUIT CAPITAL MANAGEMENT LLC Bought 63.0 Thousand shares of Immunomedics Inc
LIFESCI INDEX PARTNERS LLC Bought 35.0 Thousand shares of Immunomedics Inc